Walter Bushnell
Urofollitropin (75i.u)
Foligest 75I.U Injection is used in the treatment of female infertility, stimulating the release of estrogen to help in the growth and development of the egg before release.
Injection
Foligest 75I.U Injection is given as an injection under the supervision of a doctor. Your doctor or nurse will help you to learn the exact method of self-administration. Your doctor will decide the right time to take the injection so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed with certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Pain in abdominal pain or cramp Headache Bloating Pelvic pain Nausea Hot flushes Respiratory disorders
It is unsafe to consume alcohol with Foligest 75I.U Injection.
Information regarding the use of Foligest 75I.U Injection during breastfeeding is not available. Please consult your doctor.
Foligest 75I.U Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
In females, Foligest 75I.U Injection works by stimulating the release of estrogen which helps in the growth and development of the egg before release. It also helps to develop more follicles (eggs) in women undergoing assisted reproductive technology procedures.
Your doctor may prescribe more than one medicine as part of a pregnancy plan. The injection is administered under the skin. Follow the recommended dosage and monitoring schedules to minimise the possibility of ovarian hyperstimulation. Inform your doctor immediately if you have severe pelvic pain, nausea, vomiting, diarrhea, sudden weight gain, trouble breathing, or decreased or no urination during treatment as these could be symptoms of ovarian hyperstimulation syndrome (OHSS). Do not use Foligest 75I.U Injection if you are already pregnant or breastfeeding. Pregnancy following treatment with Foligest 75I.U Injection is more likely to result in a multiple pregnancy (twins or more) than if you had conceived naturally.
Foligest 75I.U Injection is administered as a subcutaneous injection by a healthcare professional only. The dosage and treatment duration are individualized based on your ovarian response, which will be closely monitored by your doctor throughout the therapy.
It is crucial to try not to miss a dose of Foligest 75I.U Injection. However, please consult your doctor as soon as possible if you remember missing a dose.
Common side effects include headache and abdominal pain. Other frequent side effects may include hot flushes, nausea, vomiting, diarrhea, skin rashes, and breast tenderness. If any of these side effects cause concern, please consult your healthcare provider.
Foligest 75I.U Injection contains Urofollitropin, a type of follicle stimulating hormone (FSH). It helps women who have difficulty getting pregnant due to issues with their ovaries' egg production, including polycystic ovary disease (PCOD). Foligest is also used in assisted reproductive technology (ART) procedures like in-vitro fertilization (IVF), which are designed to help couples conceive.